Formycon AG/€FYB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Formycon AG
Formycon AG is a biotechnology company based in Planegg, Germany, specializing in the development of biosimilar products. The company focuses primarily on creating biosimilar versions of top-selling biopharmaceuticals, addressing fields such as ophthalmology and immunology. Known for its significant expertise in protein and biopharmaceutical development, Formycon leverages its proprietary technical platform to advance its biosimilar pipeline. The company's strategic positioning includes partnerships with other pharmaceutical firms to co-develop and commercialize its biosimilar candidates. Formycon's competitive strength lies in its robust development capabilities and focus on high-growth therapeutic areas.
Ticker
€FYB
Sector
Primary listing
XETRA
Employees
203
Headquarters
Website
Formycon AG Metrics
BasicAdvanced
€353m
-
-€3.22
0.70
-
Price and volume
Market cap
€353m
Beta
0.7
52-week high
€30.90
52-week low
€16.64
Average daily volume
8.3k
Financial strength
Current ratio
2.091
Interest coverage (TTM)
-2.13%
Profitability
EBITDA (TTM)
11.808
Gross margin (TTM)
19.66%
Net profit margin (TTM)
-108.84%
Operating margin (TTM)
-34.74%
Effective tax rate (TTM)
31.94%
Revenue per employee (TTM)
€260,000
Management effectiveness
Return on equity (TTM)
-13.44%
Valuation
Price to revenue (TTM)
6.795
Price to book
0.92
Price to tangible book (TTM)
0.92
Price to free cash flow (TTM)
-6.051
Free cash flow yield (TTM)
-16.53%
Free cash flow per share (TTM)
-3.322
Growth
Revenue change (TTM)
-15.04%
3-year revenue growth (CAGR)
-2.02%
10-year revenue growth (CAGR)
12.29%
3-year earnings per share growth (CAGR)
145.91%
10-year earnings per share growth (CAGR)
43.70%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs